Biguanide

DB13100ApprovedWithdrawnSmall molecule

Biguanide has been investigated for the treatment of Diabetes Mellitus.

Chemical structure of Biguanide
Mechanism
Curator reviewed
Formula / weight
C2H7N5 · 101.113 g/mol (avg)

Resolves to

Compound
UNIIFB4Q52I9K2CAS56-03-1ChEBI3095PubChem5939KEGGC07672
Clinical / RWD
RxNorm1918319
Structure
InChIKeyXNCOSPRUTUOJCJ-UHFFFAOYSA-NSMILESNC(=N)NC(N)=N
Targets
P67775PPP2CA
Transporters
O15244SLC22A2O15245SLC22A1

What you can answer from here — as of October 06, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2TransportersSubstrate / inhibitor direction, not just membership
Listed above
13Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Marketed productsAcross 1 country and 1 labeller
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Biguanide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In